Search Within

Craig Nolan

Formats
  1. Meeting Abstract (30)
  2. Journal Article (28)
  3. Book Section (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (42)
  2. GSK Faculty (31)
  3. Human Oncology and Pathogenesis Program (29)
  4. Radiology, Department of (22)
  5. Neuroradiology Service (20)
  6. Population Sciences Research Program (19)

More Groups

People
  1. Lisa De Angelis (40)
  2. Igor Gavrilovic (33)
  3. Thomas Kaley (31)
  4. Ingo Mellinghoff (29)
  5. Elena Pentsova (28)
  6. Christian Grommes (27)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publications
  1. Neuro-Oncology (19)
  2. Journal of Clinical Oncology (9)
  3. Blood (5)
  4. Clinical Cancer Research (4)
  5. Journal of Neuro-Oncology (4)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. Oxford University Press (22)
  2. American Society of Clinical Oncology (9)
  3. Springer (6)
  4. American Association for Cancer Research (5)
  5. American Society of Hematology (5)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Primary neoplasms of the central nervous system in adults
    Book Section

    Nolan, C.; DeAngelis, L. M.
    In Hong, W. K.; Bast, R. C. Jr; Hait, W. N.; Kufe, D. W.; Pollock, R. E.; Weichselbaum, R. R.; Holland, J. F.; Frei, E. 3rd (Eds.) Holland-Frei Cancer Medicine. 8th ed (2010)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Pearls: Primary brain tumors
    Journal Article

    Nolan, C.; Gavrilovic, I. T.
    Seminars in Neurology (2010)

    Fulltext@MSK | Save
  • Myelopathies in patients with cancer
    Journal Article

    Graber, J. J.; Nolan, C. P.
    Archives of Neurology (2010)

    Fulltext@MSK | Save
  • Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    Journal Article

    De Braganca, K. C.; Janjigian, Y. Y.; Azzoli, C. G.; Kris, M.; Pietanza, M. C.; Nolan, C.; Omuro, A. M.; Holodny, A.; Lassman, A. B.
    Journal of Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Meeting Abstract

    Ney, D.; DeAngelis, L.; Nolan, C.; Gavrilovic, I.; Hormigo, A.; Lassman, A.; Abrey, L.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
    Journal Article

    Iwamoto, F. M.; Omuro, A. M.; Raizer, J. J.; Nolan, C. P.; Hormigo, A. L.; Lassman, A. B.; Gavrilovic, I. T.; Abrey, L. E.
    Journal of Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Sul, J.; Panageas, K. S.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Grimm, S. A.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save